News for 'Sun Pharmaceuticals'

IIT-Madras is India's Top University

IIT-Madras is India's Top University

Rediff.com15 Jul 2022

Seven Indian Institutes of Technology -- IIT-Madras, IIT-Bombay, IIT-Delhi, IIT-Kanpur, IIT-Kharagpur, IIT-Roorkee and IIT-Guwahati -- figured in the top 10 in the overall rankings.

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Lupin recalls 5.61 lakh pouches of India-made birth control pills in US

Rediff.com21 Aug 2020

Baltimore-based Lupin Pharmaceuticals Inc is recalling 5,60,922 pouches of Mibelas 24 Fe (norethindrone acetate and Ethinyl estradiol tablets and ferrous fumarate tablets) in the US, as per the latest enforcement report by the USFDA.

'I would have been the king of limited overs cricket'

'I would have been the king of limited overs cricket'

Rediff.com7 Apr 2023

'I am not envious of those who are making millions. It's their era and I had my era.'

Govt to settle almost all retro-tax cases this month

Govt to settle almost all retro-tax cases this month

Rediff.com4 Feb 2022

The government will settle almost all the retrospective tax cases this month, closing a chapter that plagued India's reputation as an investment-friendly destination, a top official said on Friday. A 2012 amendment that gave taxmen powers to go back 50 years and slap capital gains levies wherever ownership had changed hands overseas but business assets were in India, was used to raise Rs 1.1 lakh crore demand against multi-nationals such as telecom group Vodafone, pharmaceuticals company Sanofi and brewer SABMiller, now owned by AB InBev, and Cairn Energy Plc. Such demands brought uncertainty in the minds of investors.

Kashmir University PhD scholar held for seditious magazine article

Kashmir University PhD scholar held for seditious magazine article

Rediff.com17 Apr 2022

Abdul Aala Fazili was arrested from his Humhama residence as the SIA conducted searches at several locations in the city as part of its crackdown on terror and anti-national networks, the official said.

Glenmark to conduct trials of potential COVID-19 drug

Glenmark to conduct trials of potential COVID-19 drug

Rediff.com30 Apr 2020

As per the clinical trial protocol approved, 150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care. Treatment duration is a maximum of 14 days and the total study duration will be a maximum for 28 days from randomisation.

Hiring to grow by 7% in Apr-June if further lockdowns not imposed

Hiring to grow by 7% in Apr-June if further lockdowns not imposed

Rediff.com14 Apr 2021

The intent to hire in the current quarter is likely to rise by 7 per cent over the previous three months if further lockdowns and workplace operating rules are not enforced, mainly driven by demand in healthcare, pharmaceuticals, educational services, ecommerce and technology start-ups and IT, according to a report. In fact, out of the 21 sectors reviewed, more than 8 sectors will witness a 9-11 per cent rise in their intent to hire in the current quarter, TeamLease Employment Outlook Report has revealed.

Exports up 22.36%; trade deficit widens to $21.19 bn in Feb

Exports up 22.36%; trade deficit widens to $21.19 bn in Feb

Rediff.com2 Mar 2022

India's exports rose by 22.36 per cent to $33.81 billion in February on account of healthy growth in sectors like engineering, petroleum and chemicals, even as the trade deficit widened to $21.19 billion, according to preliminary data released by the commerce ministry on Wednesday. Imports during the month too jumped by about 35 per cent to $55 billion, with inbound shipments of petroleum and crude oil surging 66.56 per cent to $15 billion. The trade deficit -- the difference between imports and exports -- stood at $13.12 billion in February 2021.

How Shark Tank India 1 Winners Fared

How Shark Tank India 1 Winners Fared

Rediff.com14 Jan 2023

Of the 23 companies, eight have raised funds after Shark Tank India.

COVID-19: Russian flights with humanitarian aid land in India

COVID-19: Russian flights with humanitarian aid land in India

Rediff.com29 Apr 2021

Two Russian flights with oxygen concentrators, lung ventilation equipment, bedside monitors, medicines, including Coronavir and other essential pharmaceutical items landed in India to help the country in its fight against the COVID-19 surge.

Cipla gets nod to import Moderna vaccine for emergency use in India

Cipla gets nod to import Moderna vaccine for emergency use in India

Rediff.com29 Jun 2021

India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.

India, Pak bonhomie at WTO blossoms despite fractious bilateral relations

India, Pak bonhomie at WTO blossoms despite fractious bilateral relations

Rediff.com17 Aug 2022

Even as the bilateral relationship between the two neighbouring countries remains hostile, there is growing coordination between India and Pakistan on one multilateral forum - the World Trade Organization (WTO). Both countries have made two joint submissions at the WTO as co-sponsors in the past two months. In June, Pakistan joined India, Cuba, and 44 African countries, seeking sufficient flexibility in intellectual property rights for developing countries to fight the Covid-19 pandemic.

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Rediff.com27 Sep 2022

The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).

Sensex pare early gains; tumbles over 571 points

Sensex pare early gains; tumbles over 571 points

Rediff.com21 Mar 2022

Benchmark equity indices Sensex and Nifty pared their early gains to close nearly 1 per cent lower on Monday as surging oil prices played spoilsport amid prolonged Russia-Ukraine war. The 30-share Sensex plunged by 571.44 points or 0.99 per cent to settle at 57,292.49. During the day, it tanked 634.85 points or 1.09 per cent to 57,229.08. The broader NSE Nifty declined by 169.45 points or 0.98 per cent to finish at 17,117.60. Among Sensex constituents, Power Grid, Asian Paints, UltraTech Cement, Nestle, Hindustan Unilever Limited and HCL Technologies were among the major laggards.

Smaller towns witness strong growth in sales of medicines

Smaller towns witness strong growth in sales of medicines

Rediff.com27 May 2022

Medicine sales grew at a fast clip in smaller cities like Madurai, Meerut, Agra, and Varanasi in the last 12 months. The domestic pharmaceutical market, overall, has grown 12.3 per cent in this period, according to data from IQVIA MAT for April. MAT refers to the moving annual turnover or the turnover of the last 12 months. The data further showed that the top 30 cities contributed around 32 per cent to sales.

GST Council likely to meet early Jan; may discuss rate rationalisation

GST Council likely to meet early Jan; may discuss rate rationalisation

Rediff.com20 Dec 2021

The Centre is looking to convene a meeting of the all-powerful Goods and Service Tax Council in early January. The meeting is likely to focus on rectifying the inverted duty structure for a few more items and will also serve as a platform for pre-Budget discussions between Union Finance Minister Nirmala Sitharaman and state finance ministers, Business Standard has learnt. "The current Winter Session of Parliament ends on December 23, followed by the Christmas-New Year period. "After that we would like to have a meeting of the GST Council, depending on whether there can be a quorum," a top government official said.

4 IPOs to watch out for in 2022

4 IPOs to watch out for in 2022

Rediff.com22 Mar 2022

Once stability returns to the secondary market, companies that have obtained approval from Sebi will start tapping the market.

Banking, IT counters help Sensex zoom 936 points

Banking, IT counters help Sensex zoom 936 points

Rediff.com14 Mar 2022

Equity benchmark Sensex rallied 936 points on Monday, helped by heavy buying in banking and IT counters along with decline in oil prices amid hopes of headway in renewed diplomatic talks between Russia and Ukraine. A fresh round of talks is expected on Monday between Ukrainian and Russian officials. Rising for the fifth straight session, the BSE Sensex jumped 935.72 points or 1.68 per cent to settle at 56,486.02.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

FDI inflow hits all-time high of $83.57 bn in 2021-22

FDI inflow hits all-time high of $83.57 bn in 2021-22

Rediff.com20 May 2022

Total foreign direct investment into India rose 2 per cent to the "highest ever" $83.57 billion in 2021-22 on account of various measures like policy reforms and ease of doing business taken by the government, the commerce and industry ministry said on Friday. Total FDI comprises equity inflows, reinvested earnings and other capital. In 2020-21, the inflow stood at $81.97 billion. It was $74.39 billion in 2019-20 and $62 billion in 2018-19. "India has recorded the highest ever annual FDI inflow of $83.57 billion in 2021-22," the ministry noted in a statement.

20-30% new products may be open to USFDA inspection

20-30% new products may be open to USFDA inspection

Rediff.com23 May 2022

With all major US export-oriented drug manufacturing plants in the country up for inspection in 2022, some estimates peg that at least 20-30 per cent of the new product launches lined up for the US will be subject to on-site inspection by the US Food and Drug Administration (USFDA). The last two years saw limited physical inspections due to travel restrictions during the pandemic. "Pre-Covid, the frequency and number of inspections of manufacturing plants in India by USFDA had increased significantly," analysts from ICICI Securities Research noted. "With growing ANDA filings, especially for complex products. "We expect this trend to return with the environment normalising," analysts from ICICI Securities Research noted.

Pakistan flood death toll crosses 1,000-mark; countries step in with aid

Pakistan flood death toll crosses 1,000-mark; countries step in with aid

Rediff.com28 Aug 2022

Floods triggered by the torrential rain since June 14 have wreaked havoc, inundating a vast swathe of flat land in the south and southwest of the country.

India's Russian imports up 3.5 times on oil buys despite Western pressure

India's Russian imports up 3.5 times on oil buys despite Western pressure

Rediff.com22 Jun 2022

On the back of rising crude oil purchases, India's bill for imports from sanctions-hit Russia jumped 3.5 times in a year in April to $2.3 billion, showed data from the commerce ministry. In April, India's crude oil imports from Russia were valued at $1.3 billion, 57 per cent of India's total inbound shipments from Russia. Other major imported items during the month included coal, soybean and sunflower oil, fertilisers, and non-industrial diamonds. That month, Russia was also the fourth-largest crude petroleum supplier to India, after Iraq, Saudi Arabia, and the United Arab Emirates (UAE).

Exports rise; trade deficit widens in Jan

Exports rise; trade deficit widens in Jan

Rediff.com1 Feb 2022

The country's exports rose by 23.69 per cent to $34.06 billion in January on healthy performance by engineering, petroleum and gems and jewellery segments even as trade deficit widened to $17.94 billion during the month, according to provisional data of the commerce ministry. Imports in January grew by 23.74 per cent to $52.01 billion, the data, released on Tuesday, showed. Trade deficit widened to $17.94 billion during the month as against $14.49 billion in the same month last year.

Imports from Russia jump 33% to $1.1 bn in March

Imports from Russia jump 33% to $1.1 bn in March

Rediff.com9 May 2022

Shipments from Russia rose nearly 33 per cent to $1.1 billion in March from $831.17 million in the previous month, which was when the country mounted aggression on Ukraine and faced sanctions from Western nations, the data accessed by Business Standard shows. Growth in imports was largely on account of oil, people aware of the matter said. The Department of Commerce is learnt to have written to the Ministry of Petroleum and Natural Gas (MoPNG), seeking details of imports, including the payment mechanism, which India has not made public.

'Indian market one-eyed king in the land of the blind in 2022'

'Indian market one-eyed king in the land of the blind in 2022'

Rediff.com23 Sep 2022

'We have relatively strong growth and a healthy corporate earnings cycle as positives, but a worrisome current account deficit and high inflation as challenges.'

11 pm to 5 am Covid-19 curfew in Delhi from today

11 pm to 5 am Covid-19 curfew in Delhi from today

Rediff.com27 Dec 2021

Patients and pregnant women, people out to buy essential items, and those travelling to or from railway stations, bus stops and airports will be exempted from the night curfew that kicks in at 11 pm on Monday due to rising COVID-19 cases in Delhi, according to a DDMA order.

Govt waives import duty on Remdesivir

Govt waives import duty on Remdesivir

Rediff.com20 Apr 2021

This import duty exemption would remain in force till October 31 this year.

Amid Covid surge, govt approves ramping up remdesivir production

Amid Covid surge, govt approves ramping up remdesivir production

Rediff.com14 Apr 2021

The current total installed capacity of the seven manufacturers of remdesivir is 38.80 lakh vials per month, the Ministry of Chemicals and Fertilizers said in a statement.

Drug to treat mild, moderate COVID-19 launched in India

Drug to treat mild, moderate COVID-19 launched in India

Rediff.com20 Jun 2020

FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.

Infosys, L&T are top picks of most brokerages for Samvat 2078

Infosys, L&T are top picks of most brokerages for Samvat 2078

Rediff.com12 Nov 2021

Despite unprecedented levels of uncertainty in Samvat 2077, investors have little to complain about on the returns front. The BSE Sensex delivered returns of 38 per cent in this period, while the Nifty registered a return of over 40 per cent. As is the case in bull markets, companies in the small- and mid-capitalisation basket outperformed the benchmarks, with returns almost twice those of frontliners.

FTA: UK, India not working towards Diwali deadline

FTA: UK, India not working towards Diwali deadline

Rediff.com14 Oct 2022

The free trade agreement (FTA) talks with India are no longer working towards a Diwali deadline though negotiations are progressing well, UK Trade Secretary Kemi Badenoch has said as New Delhi expressed confidence on Friday of an "early date" for a mutually beneficial deal. "There are ongoing negotiations as we know on the FTA. There is interest on both sides to see if we can work towards a deal, an FTA, that is beneficial to both the countries at an early date," external affairs ministry spokesperson Arindam Bagchi told reporters in New Delhi. It came as External Affairs Minister S Jaishankar spoke to his UK counterpart, James Cleverly, and referenced the Roadmap 2030 bilateral agreement signed between Prime Minister Narendra Modi and former UK PM Boris Johnson in May last year, with no specific reference to the FTA.

Human Review

Human Review

Rediff.com14 Jan 2022

Human presents an ugly truth -- that some people need to die a painful death in order to facilitate the process of finding a cure for deadly diseases, observes Utkarsh Mishra.

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

Rediff.com10 Oct 2022

The Arvind Kejriwal-led AAP is trying to make inroads into BJP-ruled Gujarat where the assembly polls are due later this year.

SBI stops deals related to Russian entities under sanctions

SBI stops deals related to Russian entities under sanctions

Rediff.com3 Mar 2022

State Bank of India, the nation's largest lender, has stopped processing transactions of Russian entities that have been sanctioned by the West over Moscow's invasion of Ukraine, sources said. To effect this, SBI has issued a circular as it fears that any transaction with entities or sectors under sanction will invite sanction on it as well, sources said. No transactions involving entities, banks, ports or vessels appearing on a US, European Union or United Nations sanctions list would be processed irrespective of the currency of the transaction, they said. Payments due to such entities have to be processed by other mechanism rather than through the banking channel, sources added.

Lupin aims to enter Chinese market in the next one year

Lupin aims to enter Chinese market in the next one year

Rediff.com8 Feb 2021

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.

Health expenditure's share in GDP down

Health expenditure's share in GDP down

Rediff.com7 Dec 2021

The share of total health expenditure as part of the gross domestic product (GDP) went down to 3.3 per cent in 2017-18 from 3.8 per cent in the previous two years, according to the national health account data released on Monday by the health ministry. The share of government expenditure as part of total expenditure as well as GDP has gone up from from 3.78 per cent to 5.12 per cent between 2013-14 and 2017-18, which could also explain a decline seen in out of pocket expenditure in 2017-18. Health ministry also emphasised the increase in the government health expenditure as part of the total GDP from 1.15 per cent in 2013-14 to 1.35 per cent in 2017-18.

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

Rediff.com22 Sep 2022

One hundred and forty nine new individuals joined the rich list club of 1,103 Indians across 122 cities who cumulatively accumulated a wealth of Rs 100 trillion. Bengaluru -based Kaivalya Vohra, 19, of grocery delivery application Zepto is the youngest self-made and the youngest rich individual, according to IIFL Wealth Hurun India Rich List 2022. The report found 1,103 Indians with a networth of Rs 1,000 crore each - an increase of 62 per cent over five years. There are 221 billionaires (Rs 100 crore networth) in India on the 2022 list - down 16 compared with last year, while 13 people born in the 1990s made it to the list, all self-made.

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Rediff.com27 Apr 2021

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.